LGND

117.36

4.89% 5.47

시장 영업 전: 116.51 -0.85 -0.72%

리간드 파마 (LGND)

개요 뉴스 가격 이력 옵션 체인 Financials 토론 예측 주식 분할 배당 이력

전일 마감가:

$111.89

열려 있는:

$113.01

하루 거래량:

104.48K

Relative Volume:

0.89

시가총액:

$2.22B

수익:

$152.42M

순이익/손실:

$45.24M

주가수익비율:

46.76

EPS:

2.51

순현금흐름:

$6.97M

1주 성능:

+8.12%

1개월 성능:

+2.37%

6개월 성능:

+17.64%

1년 성능:

+61.83%

1일 변동 폭

$112.53

$117.53

1주일 범위

$107.99

$117.53

52주 변동 폭

$67.72

$129.90

리간드 파마 Stock (LGND) Company Profile

명칭

Ligand Pharmaceuticals Inc

부문

Healthcare (1176)

산업

Biotechnology (685)

전화

858-550-7500

주소

3911 SORRENTO VALLEY BLVD, SAN DIEGO, CA

직원

트위터

@Ligand_LGND

다음 수익 날짜

2024-11-07

최신 SEC 제출 서류

LGND's Discussions on Twitter

LGND을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
LGND Ligand Pharmaceuticals Inc	117.36	2.22B	152.42M	45.24M	6.97M	2.51
VRTX Vertex Pharmaceuticals Inc	427.89	110.19B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	687.80	75.58B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	647.39	38.71B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	264.99	34.18B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	117.25	28.11B	3.30B	-501.07M	1.03B	-2.1146

리간드 파마 Stock (LGND) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2024-10-03	개시	Oppenheimer	Outperform
2024-07-30	개시	RBC Capital Mkts	Outperform
2021-04-14	재개	Stephens	Overweight
2021-02-04	재확인	H.C. Wainwright	Buy
2020-10-06	개시	Barclays	Overweight
2020-03-24	다운그레이드	Argus	Buy → Hold
2020-03-10	개시	Guggenheim	Neutral
2020-02-06	개시	The Benchmark Company	Buy
2019-09-19	업그레이드	Barclays	Equal Weight → Overweight
2019-06-11	개시	Barclays	Equal Weight
2019-05-03	재확인	H.C. Wainwright	Buy
2019-03-06	재확인	H.C. Wainwright	Buy
2018-10-29	업그레이드	ROTH Capital	Neutral → Buy
2018-10-02	재확인	H.C. Wainwright	Buy
2018-09-11	재확인	Argus	Buy
2018-08-17	개시	Goldman	Neutral
2018-08-08	다운그레이드	ROTH Capital	Buy → Neutral
2018-06-21	개시	Argus	Buy
2017-12-27	재확인	H.C. Wainwright	Buy
2017-09-05	재개	H.C. Wainwright	Buy
2016-10-05	재확인	H.C. Wainwright	Buy
2016-08-05	다운그레이드	Deutsche Bank	Hold → Sell
2016-03-11	개시	Sidoti	Buy
2016-03-03	개시	H.C. Wainwright	Buy

모두보기

리간드 파마 주식(LGND)의 최신 뉴스

Jan 17, 2025

Burney Co. Grows Position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - MarketBeat

Jan 17, 2025

JPMorgan Chase & Co. Lowers Holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - MarketBeat

Jan 17, 2025

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Stock Position Lowered by JPMorgan Chase & Co. - Defense World

Jan 17, 2025

Jan 11, 2025

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat

Jan 11, 2025

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Given Average Recommendation of “Buy” by Brokerages - Defense World

Jan 11, 2025

Jan 10, 2025

LGND (Ligand Pharmaceuticals) Debt-to-EBITDA : 0.54 (As of Sep. 2024) - GuruFocus.com

Jan 10, 2025

Jan 08, 2025

Ligand Pharmaceuticals (NASDAQ:LGND) Stock Price Crosses Above 200-Day Moving AverageShould You Sell? - MarketBeat

Jan 08, 2025

Jan 01, 2025

Don't Ignore The Insider Selling In Ligand Pharmaceuticals - Simply Wall St

Jan 01, 2025

Dec 31, 2024

Principal Financial Group Inc. Boosts Stock Position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Defense World

Dec 31, 2024

Is Ligand Pharmaceuticals Incorporated's (NASDAQ:LGND) Recent Price Movement Underpinned By Its Weak Fundamentals? - Simply Wall St

Dec 31, 2024

Dec 28, 2024

Jane Street Group LLC Sells 7,790 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Defense World

Dec 28, 2024

Jane Street Group LLC Trims Position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - MarketBeat

Dec 28, 2024

Dec 27, 2024

Octavio Espinoza Executes Sell Order: Offloads $244K In Ligand Pharmaceuticals Stock - Benzinga

Dec 27, 2024

Ligand Pharmaceuticals (NASDAQ:LGND) Updates FY 2024 Earnings Guidance - MarketBeat

Dec 27, 2024

Ligand Pharmaceuticals (NASDAQ:LGND) shareholders have earned a 59% return over the last year - Yahoo Finance

Dec 27, 2024

MML Investors Services LLC Makes New Investment in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Defense World

Dec 27, 2024

Dec 26, 2024

Insider Sell Alert: Octavio Espinoza Sells Shares of Ligand Pharmaceuticals Inc (LGND) - GuruFocus.com

Dec 26, 2024

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) CFO Octavio Espinoza Sells 2,104 Shares - MarketBeat

Dec 26, 2024

Ligand Pharmaceuticals CFO Espinoza sells $244,850 in stock By Investing.com - Investing.com Canada

Dec 26, 2024

Dec 24, 2024

Benchmark maintains Buy on Ligand Pharma stock citing consistent financial performance - Investing.com Canada

Dec 24, 2024

Geode Capital Management LLC Acquires 22,495 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Defense World

Dec 24, 2024

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Holdings Raised by Geode Capital Management LLC - MarketBeat

Dec 24, 2024

Ligand Pharmaceuticals (NASDAQ:LGND) Receives “Buy” Rating from Benchmark - Defense World

Dec 24, 2024

Dec 23, 2024

Benchmark Reaffirms Buy Rating for Ligand Pharmaceuticals (NASDAQ:LGND) - MarketBeat

Dec 23, 2024

Dec 22, 2024

Franklin Resources Inc. Has $9.79 Million Stock Holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - MarketBeat

Dec 22, 2024

Barclays PLC Has $4.35 Million Stock Holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - MarketBeat

Dec 22, 2024

Dec 21, 2024

Stifel Financial Corp Raises Position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Defense World

Dec 21, 2024

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Stock Holdings Lifted by HighTower Advisors LLC - Defense World

Dec 21, 2024

Dec 20, 2024

Wellington Management Group LLP Decreases Stock Holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - MarketBeat

Dec 20, 2024

Dec 18, 2024

Fmr LLC Raises Position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - MarketBeat

Dec 17, 2024

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Given Consensus Rating of "Buy" by Brokerages - MarketBeat

Dec 17, 2024

Dec 16, 2024

Ligand Pharmaceuticals: A Strong Growth Trajectory with Impressive Returns and Strategic Advancements - mediahousepress

Dec 16, 2024

LGND: 2025 View Calls for 17% Topline Growth - Zacks Small Cap Research

Dec 16, 2024

Ligand Pharmaceuticals' SWOT analysis: diversified royalty model drives stock growth - Investing.com Australia

Dec 16, 2024

Barclays Boosts Ligand Pharmaceuticals (NASDAQ:LGND) Price Target to $160.00 - MarketBeat

Dec 16, 2024

Dec 15, 2024

Ligand Pharmaceuticals' SWOT analysis: stock poised for growth amid challenges By Investing.com - Investing.com South Africa

Dec 15, 2024

Ligand Pharmaceuticals' SWOT analysis: stock poised for growth amid challenges - Investing.com India

Dec 15, 2024

BNP Paribas Financial Markets Sells 1,586 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Defense World

Dec 15, 2024

Dec 13, 2024

Ligand Pharmaceuticals' SWOT analysis: royalty aggregator stock poised for growth - Investing.com

Dec 13, 2024

What is HC Wainwright's Estimate for LGND FY2025 Earnings? - MarketBeat

Dec 13, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 6,031 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - MarketBeat

Dec 13, 2024

The Manufacturers Life Insurance Company Sells 167 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) - Defense World

Dec 13, 2024

Dec 12, 2024

Ligand price target raised to $151 from $135 at Oppenheimer - Yahoo Finance

Dec 12, 2024